Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial

Skye Marshall; Elisabeth Isenring; Anna Elizabeth Lohning; Andy Koh; Alexandra L. McCarthy; Alex Molassiotis; Robert Bird; Ian McPherson; Catherine Shannon; Wolfgang Marx

Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial

Skye Marshall
, Elisabeth Isenring
, Anna Elizabeth Lohning
, Andy Koh
, Alexandra L. McCarthy
, Alex Molassiotis
, Robert Bird
, Ian McPherson
, Catherine Shannon
, Wolfgang Marx

Research output: Contribution to journal › Meeting Abstract › Research › peer-review

Abstract

Introduction
Research is required to explore whether ginger-mediated improvements
in chemotherapy-induced nausea and vomiting (CINV) translate into improved
quality of life (QoL). This trial assessed the efficacy (CINV incidence/
severity, QoL) and safety of a ginger supplement in adults undergoing
chemotherapy (CTX).

Original language	English
Article number	ANTIE-01
Pages (from-to)	S3-S3
Number of pages	1
Journal	Supportive Care in Cancer
Volume	30
Issue number	S1
Publication status	Published - 1 Jun 2022
Event	2022 MASCC/ISOO Annual Meeting on Supportive Care in Cancer - Canada, Toronto, Canada Duration: 23 Jun 2022 → 25 Jun 2022 https://mascc.org/meetings/past-meetings/2022-meeting-highlights/2022-annual-meeting-presentations/

Oncology Nutrition Research
Isenring, E. (Project Lead), Marshall, S. (Senior Research Fellow), Van der Meij, B. (Senior Research Fellow), Rigby, R. (Associate Investigator), Teleni, L. (HDR Student), Crichton, M. (HDR Student) & Tang, X. (Admin)
1/01/14 → …
Project: Research

Cite this

@article{5838f4a2d6e14dc9992095a8078f4d2c,

title = "Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial",

abstract = "Introduction Research is required to explore whether ginger-mediated improvements in chemotherapy-induced nausea and vomiting (CINV) translate into improved quality of life (QoL). This trial assessed the efficacy (CINV incidence/ severity, QoL) and safety of a ginger supplement in adults undergoing chemotherapy (CTX). ",

author = "Skye Marshall and Elisabeth Isenring and Lohning, \{Anna Elizabeth\} and Andy Koh and McCarthy, \{Alexandra L.\} and Alex Molassiotis and Robert Bird and Ian McPherson and Catherine Shannon and Wolfgang Marx",

year = "2022",

month = jun,

day = "1",

language = "English",

volume = "30",

pages = "S3--S3",

journal = "Supportive Care in Cancer",

issn = "0941-4355",

publisher = "Springer",

number = "S1",

note = "2022 MASCC/ISOO Annual Meeting on Supportive Care in Cancer, MASCC 2022 ; Conference date: 23-06-2022 Through 25-06-2022",

url = "https://mascc.org/meetings/past-meetings/2022-meeting-highlights/2022-annual-meeting-presentations/",

}

Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial. / Marshall, Skye ; Isenring, Elisabeth ; Lohning, Anna Elizabeth et al.
In: Supportive Care in Cancer, Vol. 30, No. S1, ANTIE-01, 01.06.2022, p. S3-S3.

Research output: Contribution to journal › Meeting Abstract › Research › peer-review

TY - JOUR

T1 - Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial

AU - Marshall, Skye

AU - Isenring, Elisabeth

AU - Lohning, Anna Elizabeth

AU - Koh, Andy

AU - McCarthy, Alexandra L.

AU - Molassiotis, Alex

AU - Bird, Robert

AU - McPherson, Ian

AU - Shannon, Catherine

AU - Marx, Wolfgang

PY - 2022/6/1

Y1 - 2022/6/1

N2 - Introduction Research is required to explore whether ginger-mediated improvements in chemotherapy-induced nausea and vomiting (CINV) translate into improved quality of life (QoL). This trial assessed the efficacy (CINV incidence/ severity, QoL) and safety of a ginger supplement in adults undergoing chemotherapy (CTX).

AB - Introduction Research is required to explore whether ginger-mediated improvements in chemotherapy-induced nausea and vomiting (CINV) translate into improved quality of life (QoL). This trial assessed the efficacy (CINV incidence/ severity, QoL) and safety of a ginger supplement in adults undergoing chemotherapy (CTX).

M3 - Meeting Abstract

SN - 0941-4355

VL - 30

SP - S3-S3

JO - Supportive Care in Cancer

JF - Supportive Care in Cancer

IS - S1

M1 - ANTIE-01

T2 - 2022 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

Y2 - 23 June 2022 through 25 June 2022

ER -

Ginger supplementation a safe and viable adjuvant to antiemetic medications for chemotherapy-induced nausea and vomiting: A randomized trial

Abstract

Fingerprint

Related Projects

Oncology Nutrition Research

Cite this